The 2 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 20.00 and a low estimate of 6.00. The median estimate represents a +274.64% increase from the last price of 3.47.
The current consensus among 3 polled investment analysts is to Hold stock in Lexicon Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Mar 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.